-
March 18, 2022 Psychedelic Business Spotlight – March 18This week in psychedelic business news: A psychedelics company folds; Ketamine Wellness Centers expand; Nova...
-
March 16, 2022 Mind Cure Health Halts All Psychedelic Business ActivityThe company was pursuing several psychedelic business strategies, including synthesizing ibogaine for researchers.
-
March 11, 2022 Psychedelic Business Spotlight- March 11This week in psychedelic business news: Small Pharma prepares big DMT studies; Health Canada approves...
-
March 4, 2022 Psychedelic Business Spotlight – March 4This week in psychedelic business news: Field Trip partners with Cerebral; Benzinga forms Psychedelic Advisory...
-
March 2, 2022 The Biggest Reason People in Oregon Want to Use PsilocybinSpoiler alert: It's not because they're depressed.
-
February 25, 2022 Psychedelic Business Spotlight – February 25This week in psychedelic business news: Core One cheapens psilocybin production; Field Trip eyes Oregon;...
-
February 24, 2022 LSD Microdosing Study Finds ‘No Residual Effects’ on Mood or CognitionAnother study concludes with results challenging the increasingly popular narrative that microdosing psychedelics improves mood...
-
February 23, 2022 4 Signs the Psychedelics Movement Is UnstoppableWith no strong resistance manifesting to oppose the psychedelic renaissance, it appears these drugs have...
-
February 18, 2022 Psychedelic Business Spotlight – February 18This week in psychedelic business news: Nova Mentis makes progress on autism; atai donates to...
-
February 15, 2022 Judge Grants Hearing for Opposition to DEA Proposal to Criminalize 5 More PsychedelicsBiotech companies and researchers opposed to five more tryptamines becoming schedule 1 controlled substances will...
